Nefritol syrup

Manufacturer
Dr. Masood Homeopathic Pharmaceuticals Private Limited
Effective date
2025-04-22
Label type
HUMAN OTC DRUG LABEL
Version
1
Source
full-release
Hydrated at
2026-06-01 02:33:27

Label at a glance#

ProductNefritol syrup
Active ingredientCHONDRODENDRON TOMENTOSUM ROOT, HYDRANGEA ARBORESCENS WHOLE, EPIGAEA REPENS, APIS MELLIFERA, BERBERIS VULGARIS WHOLE, LYTTA VESICATORIA, SOLIDAGO VIRGAUREA WHOLE, LYCOPODIUM CLAVATUM WHOLE
Label structure8 sections

Indications and uses

it is indicated for the supportive treatment of conditions related to urinary tract including its infections, pain and inflammation

Label contents#

Full prescribing information#

Indications and Usage

INDICATIONS & USAGE SECTION

it is indicated for the supportive treatment of conditions related to urinary tract including its infections, pain and inflammation

Inactive Ingredients

INACTIVE INGREDIENT SECTION

Sodium Benzoate

Sodium Saccharine

Cellulose Gum

Glycerin

Sorbotol 70%

Water

Active Ingredients

OTC - ACTIVE INGREDIENT SECTION

Berberis Vulgaris

Epigaea repens

Apis mellifica

Hydrangea arborescens

Cantharis

Pareira brava

Lycopodium clavatum

Solidago virgaurea

Purpose

OTC - PURPOSE SECTION

Ingredients Purpose

Berberis vulgaris used for urinary tract problems like calculi and infections

Epigaea repens used in Chronic cystitis with dysuria

Apis mellifica helps treat Inflammation of kidney, Burning and soreness when urinating

Hydrangea arborescens Traets Renal colic

Cantharis Helps overcome burning micturation

Pareira brava Useful in renal colic, prostatic affection and catarrh of bladder

Lycopodium clavatum useful in Urinary disturbances

Solidago virgaurea Helps in renal cloic with dysuria

Warnings

WARNINGS SECTION

Do not:

  • use if you have an allergy or hypersensitivity to components of the formula
  • use if pregnant or nursing

Stop use and ask a doctor if:

  • condition worsens
  • If symptoms persists for more than 7 days

Keep out of reach of children.

Keep out of the reach of children

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Keep this and all medicines out of the reach of children

Dosage and Administartion

DOSAGE & ADMINISTRATION SECTION

2 teaspoonful 3 times a day or as directed by licensed homeopathic practitioner

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Nefritol syrupNefritol syrup

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
82797-131-01Nefritol syrup1 in 1 BOXSYRUP11
82797-131-12Nefritol syrup120 mL in 1 BOTTLESYRUP1201

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
82797-131NEFRITOL SYRUP (BERBERIS VULGARIS 8X, EPIGEA REPENS, APIS MELLIFICA 6, HYDRANGEA ARBORESCENS , CANTHARIS 30 , PAREIRA BRAVA 3, LYCOPODIUM CLAV , SOLIDAGO VIRGAUREA) SYRUP [DR. MASOOD HOMEOPATHIC PHARMACEUTICALS PRIVATE LIMITED]12 package rows20250424_33583a6a-dba4-e2fd-e063-6294a90a10f4.zip

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 16 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
82797-13182797-131-12, 82797-131-01

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 14 matching rows.

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
33583a6a-dba5-e2fd-e063-6294a90a10f433583a6a-dba4-e2fd-e063-6294a90a10f42025-04-22WarningsExact identifier
spl id: 33583a6a-dba5-e2fd-e063-6294a90a10f4
spl set id: 33583a6a-dba4-e2fd-e063-6294a90a10f4

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.